AR073047A1 - Derivados de imidazol - Google Patents

Derivados de imidazol

Info

Publication number
AR073047A1
AR073047A1 ARP090103196A ARP090103196A AR073047A1 AR 073047 A1 AR073047 A1 AR 073047A1 AR P090103196 A ARP090103196 A AR P090103196A AR P090103196 A ARP090103196 A AR P090103196A AR 073047 A1 AR073047 A1 AR 073047A1
Authority
AR
Argentina
Prior art keywords
heterocyclyl
carbocyclyl
alkyl
optionally substituted
opportunity
Prior art date
Application number
ARP090103196A
Other languages
English (en)
Spanish (es)
Inventor
Lynsie Almeida
Claudio E Chuaqui
Stephanos Ioannidis
Huiping Guan
Bo Peng
Qibin Su
Michelle Lamb
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of AR073047A1 publication Critical patent/AR073047A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP090103196A 2008-08-19 2009-08-19 Derivados de imidazol AR073047A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9012208P 2008-08-19 2008-08-19

Publications (1)

Publication Number Publication Date
AR073047A1 true AR073047A1 (es) 2010-10-06

Family

ID=41226923

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090103196A AR073047A1 (es) 2008-08-19 2009-08-19 Derivados de imidazol

Country Status (4)

Country Link
AR (1) AR073047A1 (zh)
TW (1) TW201011017A (zh)
UY (1) UY32055A (zh)
WO (1) WO2010020810A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2554544A1 (en) * 2011-08-01 2013-02-06 Almirall, S.A. Pyridin-2(1h)-one derivatives as jak inhibitors
US20160123982A1 (en) 2013-02-04 2016-05-05 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for assaying jak2 activity in red blood cells and uses thereof
EP3359154B1 (en) * 2015-10-08 2021-05-26 Suzhou Yunxuan Yiyao Keji Youxian Gongsi Wnt signaling pathway inhibitors and therapeutic applications thereof
PE20190971A1 (es) 2016-06-13 2019-07-09 Glaxosmithkline Ip Dev Ltd Compuestos quimicos
KR20190026902A (ko) 2016-07-14 2019-03-13 화이자 인코포레이티드 바닌-1 효소의 억제제로서의 신규 피리미딘 카르복스아미드
WO2018167283A1 (en) 2017-03-17 2018-09-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma associated neural remodeling
WO2018189335A1 (en) 2017-04-13 2018-10-18 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the diagnosis and treatment of pancreatic ductal adenocarcinoma
WO2020092015A1 (en) 2018-11-02 2020-05-07 University Of Rochester Therapeutic mitigation of epithelial infection
CN112094227B (zh) * 2020-05-29 2021-04-16 凯美克(上海)医药科技有限公司 一种1-（5-氯-3-氟吡啶-2-基）乙胺的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2375735T3 (es) * 2005-02-04 2012-03-05 Astrazeneca Ab Derivados de pirazolilaminopiridina útiles como inhibidores de quinasas.
WO2007031745A1 (en) * 2005-09-16 2007-03-22 Astrazeneca Ab Pyrimidine derivatives for the inhibition of igf-ir tyrosine kinase activity
EP2388259A1 (en) * 2005-10-28 2011-11-23 AstraZeneca AB 4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
WO2008117050A1 (en) * 2007-03-27 2008-10-02 Astrazeneca Ab Pyrazolyl-amino-substituted pyrazines and their use for the treatment of cancer

Also Published As

Publication number Publication date
TW201011017A (en) 2010-03-16
UY32055A (es) 2010-03-26
WO2010020810A1 (en) 2010-02-25

Similar Documents

Publication Publication Date Title
AR073047A1 (es) Derivados de imidazol
AR073327A1 (es) Heterociclos nitrogenados y su uso como anticancerigenos
AR069899A1 (es) Compuestos quimicos derivados de pirazol-triazina
PE20141066A1 (es) Compuestos de benzotiazol
AR066147A1 (es) Pirazol-pirimidinas, composicion farmaceutica, proceso y uso en trastornos mieloproliferativos, sindrome mielodisplasico y cancer
CO6541645A2 (es) Compuestos de indol y su uso farmaceutico
AR076900A1 (es) Derivados heterociclicos nitrogenados utiles como agentes antivirales, composiciones farmaceuticas que los contienen y uso de los mismos como inhibidores del vhc
AR055076A1 (es) Derivados de1,1-dioxido de 1,4-benzotiazepina,procedimiento para prepararlos,composiciones farmaceuticas que los contienen y usos en terapeutica.
PH12015502534A1 (en) Benzimidazole derivatives as bromodomain inhibitors
CR20150401A (es) Formas de rifaximina y sus usos
PE20141182A1 (es) Derivados fusionados de aminodihidrotiazina
EA201170922A1 (ru) Производные сульфонамида
CO6741203A2 (es) Derivados de biciclo[3,2,1]octilamida y sus usos
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
CU20110235A7 (es) Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17
HN2012000263A (es) Derivados n1-sulfonil-5-fluoropirimidinona
AR053334A1 (es) Pirazolilcarboxanilidas
SV2011004077A (es) Derivados aminobutiricos sustituidos como inhibidores de neprilisina
CR8756A (es) Derivados de acido carboxilico bencimidazolona
AR063101A1 (es) Derivados de pirazina-2-carboxiamida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento o profilaxis de enfermedades asociadas con la modulacion de receptores del cb2.
UY30082A1 (es) Forma cristalina de 1-(1-metiletil)-4`-((2-fluoro-4-metoxifenil)metil)-5`- metil-1h-pirazol-3`-o-b-d-glucopiranosido, un metodo para su preparacion y el uso de la misma para preparar medicamentos
SV2006002232A (es) Inhibidores bace ref. x-16940
CR20140294A (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
AR066429A1 (es) Derivados de imidazolopiridina y purina como inhibidores de tirosina quinasa
SV2011003997A (es) Pirimidinas fusionadas

Legal Events

Date Code Title Description
FB Suspension of granting procedure